Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma.
about
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxiaLenalidomide in lymphomas and chronic lymphocytic leukemia.Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
P2860
Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@ast
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@en
type
label
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@ast
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@en
prefLabel
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@ast
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@en
P2860
P356
P1476
Lenalidomide induced good clin ...... refractory Hodgkin's lymphoma.
@en
P2093
Inga Mandac
Slobodanka Ostojic Kolonic
P2860
P2888
P356
10.1186/1756-8722-3-20
P577
2010-05-28T00:00:00Z
P5875
P6179
1048738432